Analyst Ratings for AstraZeneca (AZN) [Neutrals]

AZN Rating Summary

AZN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AZN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $63.75 (+9.1%) * Over Last 12-Mos
Rating Score: 6.1 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/12/2021 Argus
» Updated 4/14/2021
John Eade Downgrade Hold
(Buy)
N/A
(N/A)
49.94
(58.42)
16.98% Details
7/28/2017 Morgan Stanley N/A Downgrade Equalweight
(Overweight)
N/A
(N/A)
28.88
(58.42)
102.29% Details
Like AZN Ratings? Also take a look at PFE, MRNA, JNJ, BNTX

AZN Ratings News